Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iman Daryaei

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Research and Reports in Nuclear Medicine|October 18, 2016
Double agents and secret agents: the emerging fields of exogenous chemical exchange saturation transfer and T<sub>2</sub>-exchange magnetic resonance imaging contrast agents for molecular imagingIman Daryaei, Mark D Pagel
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 4, 2017
Detection of DT-diaphorase Enzyme with a ParaCEST MRI Contrast AgentIman Daryaei, Kyle M Jones, Mark D Pagel
Magnetic Resonance in Medicine|April 20, 2016
A biomarker-responsive T<sub>2ex</sub> MRI contrast agentIman Daryaei, Edward A Randtke, Mark D Pagel
Medchemcomm|February 13, 2019
Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst<sub>4</sub>) receptorIman Daryaei, Karin Sandoval, Ken Witt, et al.
ACS Sensors|September 25, 2018
Detection of Alkaline Phosphatase Enzyme Activity with a CatalyCEST MRI BiosensorIman Daryaei, Mahsa Mohammadebrahim Ghaffari, Kyle M Jones, et al.
Pancreas|February 27, 2016
Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 InhibitorJoseph E Kobes, Iman Daryaei, Christine M Howison, et al.
Investigative Radiology|June 23, 2020
Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal AdenocarcinomaRakesh Bam, Iman Daryaei, Lotfi Abou-Elkacem, et al.
Frontiers in Pharmacology|June 30, 2026
Comparative evaluation for small molecule somatostatin 4 receptor agonists: <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> approachesDóra Biskup, Minjin Ganbold, Andrea Kinga Nehr-Majoros, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Research and Reports in Nuclear Medicine|October 18, 2016
Double agents and secret agents: the emerging fields of exogenous chemical exchange saturation transfer and T<sub>2</sub>-exchange magnetic resonance imaging contrast agents for molecular imagingIman Daryaei, Mark D Pagel
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 4, 2017
Detection of DT-diaphorase Enzyme with a ParaCEST MRI Contrast AgentIman Daryaei, Kyle M Jones, Mark D Pagel
Magnetic Resonance in Medicine|April 20, 2016
A biomarker-responsive T<sub>2ex</sub> MRI contrast agentIman Daryaei, Edward A Randtke, Mark D Pagel
Medchemcomm|February 13, 2019
Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst<sub>4</sub>) receptorIman Daryaei, Karin Sandoval, Ken Witt, et al.
ACS Sensors|September 25, 2018
Detection of Alkaline Phosphatase Enzyme Activity with a CatalyCEST MRI BiosensorIman Daryaei, Mahsa Mohammadebrahim Ghaffari, Kyle M Jones, et al.
Pancreas|February 27, 2016
Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 InhibitorJoseph E Kobes, Iman Daryaei, Christine M Howison, et al.
Investigative Radiology|June 23, 2020
Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal AdenocarcinomaRakesh Bam, Iman Daryaei, Lotfi Abou-Elkacem, et al.
Frontiers in Pharmacology|June 30, 2026
Comparative evaluation for small molecule somatostatin 4 receptor agonists: <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> approachesDóra Biskup, Minjin Ganbold, Andrea Kinga Nehr-Majoros, et al.
Pageof 1